Form 4 Filing for Arcus Biosciences, Inc. - Andrew J. Perlman

This filing details a Form 4 submission for Arcus Biosciences, Inc. (RCUS) concerning transactions by Andrew J. Perlman. On June 11, 2026, Mr. Perlman was granted 5,700 shares of Common Stock and 16,900 stock options. The restricted stock units (RSUs) vest fully on the earlier of June 11, 2027, or the next annual stockholders meeting, and will also vest upon a change in control of the company. Similarly, the stock options, with an exercise price of $23.30, vest fully on the earlier of June 11, 2027, or the next annual stockholders meeting, and become fully exercisable upon a change in control. Mr. Perlman holds these securities directly, with post-transaction holdings of 48,325 shares of Common Stock and 16,900 stock options.